赛派号

500以内路亚竿推荐 China Traditional Chinese Medicine Holdings (570) Investor Relations, Earnings Summary & Outlook

Revenue for the six months ended 30 June 2025 was RMB7,463.4 million, down 11.0% year-over-year, mainly due to increased centralised procurement, intensified competition, and strategic business adjustments.

Gross profit decreased by 10.5% to RMB3,634.6 million, but gross margin improved slightly to 48.7% due to sales structure optimization.

Net loss for the period was RMB141.8 million, compared to a profit of RMB214.1 million in the prior year, mainly due to lower sales, goodwill impairment, and increased credit loss provisions.

No interim dividend was declared for the period.

版权声明:本文内容由互联网用户自发贡献,该文观点仅代表作者本人。本站仅提供信息存储空间服务,不拥有所有权,不承担相关法律责任。如发现本站有涉嫌抄袭侵权/违法违规的内容, 请发送邮件至lsinopec@gmail.com举报,一经查实,本站将立刻删除。

上一篇 没有了

下一篇没有了